• Explore /
  • Poster
  • / A pilot study evaluating the safety, tolerability, and efficacy of doxorubicin and pembrolizumab in patients with metastatic or unresectable soft tissue sarcoma.

A pilot study evaluating the safety, tolerability, and efficacy of doxorubicin and pembrolizumab in patients with metastatic or unresectable soft tissue sarcoma.

Abstract Video & Slides Poster

Authors

null

Michael B. Livingston

Levine Cancer Institute, Atrium Health, Charlotte, NC

Michael B. Livingston , Megan Jagosky , Myra M. Robinson , William Ahrens , Jennifer H Benbow , Carol J. Farhangfar , David Foureau , Deirdre Maxwell , Emily Baldrige , Nury Steuerwald , Colin J Anderson , Joshua Patt , Jeffrey Kneisl , Edward S. Kim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03056001

Citation

J Clin Oncol 38: 2020 (suppl; abstr 11519)

DOI

10.1200/JCO.2020.38.15_suppl.11519

Abstract #

11519

Poster Bd #

407

Abstract Disclosures

Similar Posters

First Author: Zhendong Chen

First Author: Eoghan Ruadh Malone

First Author: Eoghan Ruadh Malone

First Author: Frederick C. Eilber